Solid Biosciences Inc. (NASDAQ: SLDB) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SOLID BIOSCIENCES INC.

Solid Biosciences Inc. (NASDAQ: SLDB)
Listen to this Section


$7.36
+0.5120 ( +7.47% ) 212.9K

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Clinical Trial Pipeline Stages


Drug Name Stage
SGT-003DetailsGenetic disorder, Duchenne muscular dystrophy Phase 1/2
SGT-001 (Microdystrophin Gene Transfer)DetailsGenetic disorder, Muscle weakness, Muscle degeneration Failed

Market Data


Open $7.36
Previous Close $6.85
Volume 212.9K
Market Cap $674.38M
Day Range $6.68 - $7.41
52 Week Range $3.41 - $8.87
Shares Outstanding 98.45M
Change % +7.47%
Net Change ▲ 0.5120
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
IPO Year2018
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 1,297,008.00

Date Type Amount Purchased Purchaser
2024-04-05 Sale -3256.00 SMITH IAN F
2024-02-16 Sale -117500.00 Howton David T
2024-02-16 Sale -85000.00 Tan Kevin
2024-02-16 Sale -90000.00 Marlowe Jennifer
2024-02-16 Sale -57500.00 Herzich Paul
2024-02-16 Sale -19444.00 Ganot Ilan
2024-02-16 Sale -240250.00 Cumbo Alexander
2024-02-16 Sale -65000.00 Hanrahan Jessie
2024-02-16 Sale -87500.00 Brooks Gabriel
2024-01-30 Sale -388.00 Ganot Ilan

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 13, 2025
10-q Quarterly Reports 68 Nov 03, 2025
8-k 8K-related 64 Nov 03, 2025
4 Insider transactions 1 Oct 21, 2025
4 Insider transactions 1 Oct 07, 2025
4 Insider transactions 1 Aug 18, 2025
4 Insider transactions 1 Aug 18, 2025
4 Insider transactions 1 Aug 18, 2025
4 Insider transactions 1 Aug 18, 2025
4 Insider transactions 1 Aug 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy